BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, April 25, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Financings for March 31, 2023

March 31, 2023
Biopharmas raising money in public or private financings, including: Alligator, Aptevo, Checkpoint, Medexus, Renovorx, TC, Xoma, Zealand.
Read More

Appointments and advancements for March 31, 2023

March 31, 2023
New hires and promotions in the biopharma industry, including: Alaunos, Biocryst, Sensorion, Tscan.
Read More

Regulatory actions for March 30, 2023

March 30, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Aevice Health, Bioretec.
Read More

Other news to note for March 30, 2023

March 30, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ad Astra Diagnostics, Bigfoot Biomedical, FVRS, Fundamentalvr, Haply, Illumina, Sonex, Stilla.
Read More

In the clinic for March 30, 2023

March 30, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: C2n Diagnostics, Ciliatech, Vaxxas.
Read More

Financings for March 30, 2023

March 30, 2023
Med-tech firms raising money in public or private financings, including: Delcath Systems, Watershed Informatics.
Read More

Appointments and advancements for March 30, 2023

March 30, 2023
New hires and promotions in the med-tech industry, including: American Laboratory Products, NEC Corp. of America, Somalogic, Supira Medical.
Read More

Regulatory actions for March 30, 2023

March 30, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Blueprint, Eloxx, Epicentrx, Hansa, Juno, Pharmather, Regeneron, Transcenta.
Read More

Other news to note for March 30, 2023

March 30, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alector, Apollomics, Aquestive, Aridis, Astrazeneca, Celularity, Galimedix, Otonomy, Pharmanovia, Smart Immune, Spiral, Thea, Unravel.
Read More

In the clinic for March 30, 2023

March 30, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Achieve, Affimed, Biogen, Bioxytran, Caribou, Corcept, Evaxion, Harmony, Netris, Precigen, Rapt.
Read More
Previous 1 2 … 813 814 815 816 817 818 819 820 821 … 1786 1787 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 24, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 21, 2026
  • Boy cupping ear with soundwave graphic

    A free gene therapy? Regeneron’s Otarmeni approved for hearing loss

    BioWorld
    Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
  • Illustration of metastatic cancer

    At AACR: Epigenetic fingerprints in metastases track tumor origin

    BioWorld
    When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
  • Illustration of human face that looks abstract and digital

    AACR 2026: The age of agentic AI in oncology

    BioWorld Science
    New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing